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Abstract
Introduction Decreases in oxygen saturation (SO2) and lactate
concentration [Lac] from superior vena cava (SVC) to
pulmonary artery have been reported. These gradients (ΔSO2
and Δ[Lac]) are probably created by diluting SVC blood with
blood of lower SO2 and [Lac]. We tested the hypothesis that
ΔSO2 and Δ[Lac] result from mixing SVC and inferior vena cava
(IVC) blood streams.
Methods This was a prospective, sequential, observational
study of hemodynamically stable individuals with pulmonary
artery hypertension (n = 9) who were about to undergo right
heart catheterization. Catheters were advanced under
fluoroscopic guidance into the IVC, SVC, right atrium, right
ventricle, and pulmonary artery. Samples were obtained at each
site and analyzed for SO2, [Lac], and glucose concentration
([Glu]). Analysis of variance with Tukey HSD test was used to
compare metabolite concentrations at each site.
Results There were no differences in SO2 or [Lac] between IVC
and SVC, both being greater than their respective pulmonary
artery measurements (P < 0.01 for SO2 and P < 0.05 for [Lac]).
SO2 and [Lac] in right atrium, right ventricle, and pulmonary
artery were similar. ΔSO2 was 4.4 ± 1.4% (mean ± standard
deviation) and Δ[Lac] was 0.16 ± 0.11 mmol/l (both > 0; P <
0.001).  Δ[Glu] was -0.19 ± 0.31 mmol/l, which was not
significantly different from zero, with SVC [Glu] being less than
IVC [Glu].
Conclusion Mixing of SVC with IVC blood does not account for
the development of ΔSO2 and Δ[Lac] in hemodynamically stable
individuals with pulmonary artery hypertension. An alternate
mechanism is mixing with coronary sinus blood, implying that
ΔSO2 and Δ[Lac] may reflect changes in coronary sinus SO2
and [Lac] in this patient population.
Introduction
Blood oxygen saturation (SO2) in the superior vena cava
(SVC) is approximately 2% to 5% higher than that in the pul-
monary artery [1,2]. This SVC-pulmonary artery gradient in
SO2 varies considerably among individuals, or even within the
s a m e  p e r s o n  w h e n  i t  i s  m e a s u r e d  a t  d i f f e r e n t  t i m e s  [ 3 ] .
Declines in blood lactate concentration ([Lac]) from right
atrium to pulmonary artery (Δ[Lac]) have also been reported
[4]. The SO2 and [Lac] gradients (ΔSO2 and Δ[Lac]) probably
develop as SVC blood mixes with blood from the inferior vena
cava (IVC) or from the heart's venous drainage, comprised of
blood emanating from the coronary sinus and Thebesian veins;
alternatively (and more likely), blood from both sources mixes
at varying proportions [5].
[Glu] = glucose concentration; IVC = inferior vena cava; [Lac] = lactate concentration; SO2 = oxygen saturation; SVC = superior vena cava.Critical Care    Vol 11 No 2    Gutierrez et al.
Page 2 of 7
(page number not for citation purposes)
Monitoring ΔSO2 and Δ[Lac] may be of little clinical interest if
these gradients are produced exclusively by mixing of SVC
and IVC blood streams. On the other hand, if ΔSO2 and Δ[Lac]
result from mixing of SVC with coronary venous blood, either
in part or in whole, then it is possible for these gradients to
reflect alterations in myocardial oxidative metabolism [4,6].
The heart is the most aerobic of organs, normally deriving its
energy from the oxidation of free fatty acids and lactate, and
coronary venous blood normally has the lowest SO2 of any
venous blood [7]. Moreover, myocardial lactate oxidation
accounts for 10% to 20% of total myocardial aerobic energy
production, and coronary venous [Lac] is substantially lower
than that of other venous effluents [8].
To test the hypothesis that ΔSO2 and Δ[Lac] result exclusively
from mixing of SVC and IVC blood streams, we measured con-
centrations of oxygen and [Lac] in the central veins, the right
heart chambers, and the pulmonary artery of hemodynamically
stable individuals who were about to undergo right heart cath-
eterization. Additionally, we measured the glucose concentra-
tion ([Glu]) in the aforementioned sites, because this substrate
is also known to play an important role in myocardial energy
metabolism.
Materials and methods
This was a prospective, sequential observational study con-
ducted in persons of either sex admitted to The George Wash-
ington University Hospital with a diagnosis of pulmonary artery
hypertension who were scheduled to undergo right heart cath-
eterization. The institutional review board approved the study
with the exclusion of drawing arterial blood samples. All
patients underwent cardiac catheterization in order to evaluate
cardiac function and pulmonary artery pressures, and were not
healthy volunteers. Written informed consent was obtained
from each patient.
Nine individuals who were older than 18 years, of either sex,
were enrolled sequentially in the study. All patients were
ambulatory. Patients were sedated before the procedure with
4 to 8 mg midazolam intravenously. Electrocardiograph leads
were monitored continuously and arterial blood pressure was
measured in the right arm at 1 min intervals using an auto-
mated inflatable blood pressure measuring device. Supple-
mental oxygen by mask was given to maintain arterial SO2,
measured by pulse oximetry, above 98% at all times during the
procedure. An 8 Fr venous sheath was placed in the right fem-
oral vein and a 7 Fr Van Aman pigtail catheter (Cook, Bloom-
ington, IN, USA) was inserted under sterile technique and
guided under fluoroscopy into the IVC just above the dia-
phragm (IVC site). It was then advanced successively into the
SVC, approximately 5 cm above the right atrium (SVC site),
the right atrium (right atrium site), the right ventricle (right ven-
tricle site), and pulmonary artery (pulmonary artery site). A
small amount of non-ionic contrast media was injected with the
catheter in the right atrium to rule out the presence of a patent
foramen ovale or septal defects. In one individual the catheter
was inserted through the right jugular vein and proper posi-
tioning at sampling each site was also confirmed fluoroscopi-
cally. Measurement of hydrostatic blood pressure at each site
was followed by the drawing of 1.5 ml blood aliquots, with the
first 2 ml of blood drawn from the catheter discarded to pre-
vent contamination with flushing fluid. The Van Aman catheter
was removed and exchanged for a 7.5 Fr pulmonary artery
catheter (Swan-Ganz standard thermodilution pulmonary
artery catheter; Edwards Life Sciences, Irvine, CA, USA) and
measurements were taken of cardiac output in triplicate using
the thermodilution method and pulmonary artery occlusion
pressure. Cardiac index was computed by dividing cardiac
output by the patient's body surface area.
Blood samples were immediately placed in ice and promptly
analyzed in triplicate [9] for SO2 saturation (IL682 CO-Oxime-
ter; Instrumentation Laboratories, Lexington, MA, USA), and
[Lac] and [Glu] (YSI 2300 STAT Plus Lactate/Glucose Instru-
ment; YSI Company, Yellow Springs, OH, USA). The YSI
2300 STAT Plus measures [Lac] and [Glu] in whole blood and
has been used in studies of blood [Lac] in critically ill individu-
als [10.11]. The accuracy of whole blood lactate measure-
ments, as compared with those in plasma, was previously
established [12]. The reported precision of blood lactate
measurements [13] with the YSI 2300 STAT Plus is 0.06
mmol/l for lactate values below 2.5 mmol/l. In the present
study, we found the precision of the three repeated measure-
ments to be 0.86% for SO2, 0.09 mmol/l for [Lac], and 0.21
mmol/L for [Glu].
Statistical analysis
Analysis of variance for repeated measures was used to com-
pare mean SO2, [Lac], and [Glu] at each sampling site. The
Tukey HSD test [14] was performed for multiple comparisons
among sampling sites whenever the F ratio was significant.
The gradient Δ in the various parameters is defined as the dif-
ference between SVC and pulmonary artery. Unless stated
otherwise, data are expressed as mean ± standard deviation,
with P < 0.05 denoting a statistically significant difference.
Results
Table 1 shows mean hydrostatic blood pressures measured at
each sampling site as well as pulmonary artery occlusion pres-
sure, mean arterial pressure, and cardiac index. Table 2 shows
individual SO2 and [Lac] measured at each sampling site, and
Figure 1 shows graphs of mean ± standard error values for
SO2 and [Lac]. There were no differences in SO2 between IVC
and SVC. SO2 levels at the IVC and SVC were greater than
that at the pulmonary artery (P < 0.01) and were greater than
SO2 at the right atrium and right ventricle sites (P < 0.01 for
IVC and P < 0.05 for SVC). There were no differences in SO2
among right atrium, right ventricle, and pulmonary artery sites.
ΔSO2 was 4.4 ± 1.4%, which was significantly different from
zero (P < 0.001).Available online http://ccforum.com/content/11/2/R44
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There were no differences in [Lac] between the IVC and SVC
sites. IVC [Lac] and SVC [Lac] were greater than pulmonary
arterial [Lac] (P < 0.01 for IVC and P < 0.05 for SVC). IVC
[Lac] was also greater than right atrial and right ventricular
[Lac]. There were no differences in [Lac] among right atrium,
right ventricle and pulmonary artery sites. Δ[Lac] was 0.16 ±
0.11 mmol/l, which was significantly different from zero (P <
0.001).
Figure 2 shows the [Glu] values for each sampling site. [Glu]
at the SVC was significantly lower than that at the IVC, right
atrium, and right ventricle sites (P < 0.01, P < 0.05, and P <
0.05, respectively). There were no differences in [Glu] among
the IVC, right atrium, right ventricle, and pulmonary artery sites.
Δ[Glu] was -0.19 ± 0.31 mmol/l, which was not significantly
different from zero.
Discussion
The aim of the present study was to test the hypothesis that
the mechanism responsible for the development of SO2 and
[Lac] gradients from SVC to pulmonary artery is mixing of SVC
with IVC blood. To that end, we measured the steady state
concentration of oxygen and [Lac] in the central veins, the right
heart chambers, and the pulmonary artery in hemodynamically
stable individuals who were suspected of having elevated pul-
monary artery pressures.
Several studies [1-3,15-26] have compared SO2 in SVC with
that in the pulmonary artery. The majority of these studies
found decreases in SO2 as blood travels from SVC to pulmo-
nary artery. The average ΔSO2 of 4.4% found in the present
study agrees with mean values of 3% to 5% reported by oth-
ers. According to our results, however, mixing of SVC with IVC
blood cannot account for the development of ΔSO2  and
Δ[Lac], as noted in this patient population. The average con-
centrations of oxygen and lactate in SVC and IVC blood were
indistinguishable from each other. Moreover, SO2 and [Lac] in
the SVC and IVC were both greater than the respective pul-
monary artery values. Therefore, it would be physically impos-
sible for the mixing of SVC and IVC blood streams to produce
pulmonary artery blood of lesser SO2 and [Lac].
The numerical average of IVC and SVC SO2 (mean SO2 =
[IVC SO2 + SVC SO2]/2) provides a first order estimate of
right atrial SO2. Assuming no input whatever from other
venous sources, such as coronary sinus, the estimate for right
atrial SO2 computed in this manner should equal pulmonary
arterial SO2. Table 3 shows differences between computed
mean SO2 and pulmonary arterial SO2 reported in published
studies measuring SO2 in the central veins, the right heart, and
pulmonary artery in humans [27-31]. With the exception of a
subset of eight patients who were 'not in shock', reported by
Lee and coworkers [31], all studies find that mean SO2 was
greater than pulmonary arterial SO2. The combined average
difference for the group is 1.82 ± 0.78%, a value significantly
different from zero (P < 0.05). These data also fail to support
the hypothesis of mixing SVC with IVC blood as the sole
mechanism for ΔSO2 in hemodynamically stable individuals.
Given that two-thirds of the systemic venous return in adults is
via the IVC [32], the magnitude of the difference between
mean SO2 and pulmonary arterial SO2 would have been even
greater if more weight had been placed on IVC SO2 in the
computation of mean SO2.
Few studies have reported on the distribution of SO2 in the
central veins and right heart in shock states. Lee and cowork-
ers [31] noted that IVC SO2 and SVC SO2 were 49.1% and
65.8%, respectively, in five patients with cardiogenic shock
(cardiac index 1.7 l/min per m2). Pulmonary arterial SO2 was
nearly equal to the computed mean SO2, indicating a predom-
inant role for IVC SO2 in the formation of ΔSO2. No compara-
ble studies in septic shock have been reported. Dahn and
coworkers [33] measured hepatic venous SO2 in 15 septic
patients and found a normal pulmonary arterial SO2 of 70.5%
at a time when hepatic venous SO2 was 55.6%. Similar find-
ings were reported by De Backer and colleagues [34], who
measured hepatic venous SO2 in 42 septic patients and noted
pulmonary arterial SO2 and hepatic venous SO2 to be 67.3%
and 50.3%, respectively. Little insight can be gained from
these data into the genesis of ΔSO2 in septic shock, because
neither IVC SO2  nor SVC SO2  were measured in these
studies.
Ours is the only study to report the distribution of [Lac] in the
central vasculature, and only two other studies have compared
lactate concentrations in SVC and pulmonary artery. Weil and
coworkers [35] found no differences between SVC [Lac] and
pulmonary arterial [Lac] in 12 patients. Conversely, we meas-
ured a Δ[Lac] of 0.2 mmol/l in 45 critically ill individuals in
which blood samples were obtained from the proximal and dis-
tal ports of pulmonary artery catheters [4]. The present study
Table 1
Hydrostatic pressures and cardiac index
Parameter Value
IVC (mmHg) 18.1 ± 8.2
SVC (mmHg) 13.0 ± 7.4
RA (mmHg) 14.0 ± 11.0
RV (mmHg) 20.5 ± 7.6
Pulmonary artery (mmHg) 38.4 ± 14.1
PAOP (mmHg) 14.6 ± 11.6
MAP (mmHg) 93.9 ± 11.9
CI (l/min per m2)2 . 6  ±  0 . 6
Nine patients were included. Values are expressed as mean ± 
standard deviation. CI, cardiac index; IVC, inferior vena cava; MAP, 
mean arterial pressure; PAOP, pulmonary artery occlusion pressure; 
RA, right atrium; RV, right ventricle; SVC, superior vena cava.Critical Care    Vol 11 No 2    Gutierrez et al.
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corroborates our previous finding that a measurable [Lac] gra-
dient exists between SVC and pulmonary artery. We also
noted that pulmonary arterial [Lac] was lower than either SVC
[Lac] or IVC [Lac], a finding that also refutes the idea of mixing
SVC and IVC blood as the mechanism for development of
Δ[Lac].
The finding of greater SO2 and [Lac] in IVC and SVC than in
pulmonary artery indicates that further dilution of oxygen and
[Lac] takes place as blood flows through the right heart cham-
bers. Given the vigorous myocardial extraction of oxygen and
lactate, venous concentrations of those chemical species are
lowest in coronary venous blood, which includes blood ema-
nating from coronary sinus and the Thebesian system. There-
fore, it is possible that blood flowing from the coronary sinus
and Thebesian veins exerted a small but measurable diluting
effect on right atrial SO2 and right atrial [Lac]. We lacked
direct samples of coronary venous blood and cannot prove
this hypothesis conclusively from the data presented. Lending
support this notion, however, are the observations that signifi-
cant decreases in SO2 and [Lac] occurred mainly in the right
atrium, which is the anatomical location of the coronary sinus
(Figure 1).
We found that the distribution pattern for [Glu] differed from
those of SO2 and [Lac]. SVC [Glu] was lower than IVC [Glu],
reflecting the high rate of cerebral glucose uptake. In adult
humans glucose represents the main, if not the sole, substrate
of brain energy metabolism, with the brain utilizing approxi-
mately 25% of circulating blood glucose [36,37]. In contrast
Table 2
Individual measurements of SO2 and [Lac], and their gradients, obtained by sampling different sites during right heart 
catheterization
Patient number IVC SVC RA RV PA ΔSO2 or Δ[Lac]
SO2 (%)
1 80.9 76.5 75.6 72.5 71.9 ΔSO2 = 4.7
2 77.5 69.1 65.6 66.5 64.5 ΔSO2 = 4.6
3 72.9 69.2 67.7 67.5 66.3 ΔSO2 = 2.9
4 68.2 67.4 63.1 62.8 61.5 ΔSO2 = 5.9
5 61.9 59.2 52.6 51.9 52.6 ΔSO2 = 6.6
6 78.7 84.5 79.2 80.0 79.7 ΔSO2 = 4.7
7 84.7 81.5 80.6 79.2 79.7 ΔSO2 = 1.8
8 59.8 55.9 55.2 55.9 52.7 ΔSO2 = 3.2
9 50.3 57.4 53.1 51.8 51.9 ΔSO2 = 5.5
Mean 70.5 69.0 65.8*† 65.3*† 64.5*‡ ΔSO2 = 4.4
SD 11.4 10.4 10.9 10.8 11.0 ΔSO2 = 1.6
[Lac] (mmol/l)
1 0.43 0.55 0.41 0.40 0.38 Δ[Lac] = 0.17
2 2.17 1.98 1.91 1.95 1.93 Δ[Lac] = 0.05
3 1.07 1.00 0.89 0.87 0.90 Δ[Lac] = 0.10
4 1.39 1.24 1.25 0.97 0.89 Δ[Lac] = 0.34
5 1.53 1.25 1.18 1.20 1.24 Δ[Lac] = 0.01
6 0.63 0.86 0.62 0.66 0.63 Δ[Lac] = 0.23
7 1.09 0.86 0.79 0.79 0.63 Δ[Lac] = 0.23
8 1.04 1.21 0.98 1.08 1.09 Δ[Lac] = 0.12
9 0.86 0.98 0.86 0.86 0.85 Δ[Lac] = 0.14
Mean 1.13 1.10 0.99§ 0.97§ 0.95*† Δ[Lac] = 0.16
SD 0.52 0.40 0.43 0.43 0.45 Δ[Lac] = 0.10
Nine patients were included. * P < 0.01, §P < 0.05 compared with IVC. ‡P < 0.01, †P < 0.05 compared with SVC. CI, cardiac index; IVC, inferior 
vena cava; [Lac], lactose concentration; MAP, mean arterial pressure; PAOP, pulmonary artery occlusion pressure; RA, right atrium; RV, right 
ventricle; So2, oxygen saturation; SVC, superior vena cava.Available online http://ccforum.com/content/11/2/R44
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to the distributions noted for SO2 and [Lac], right atrial [Glu]
was greater than SVC [Glu] but nearly equal to IVC [Glu]. This
concentration distribution is that expected for a metabolite
whose coronary sinus concentration approximates that of
SVC blood, such as may be the case for glucose in fully aero-
bic conditions [7]. It remains to be seen whether the [Glu] pat-
tern changes with myocardial hypoxia, as glucose becomes
the preferred metabolic substrate of the heart and coronary
sinus [Glu] declines in relation to IVC [Glu] [8].
The individuals studied had elevated pulmonary arterial pres-
sures, and patients with pulmonary arterial hypertension fre-
quently have right-sided valvular regurgitation, right ventricular
dilatation, and right-to-left shunts through a patent foramen
ovale. Angiography did not reveal patent foramina or septal
defects in any of the patients included in this study. Given their
moderate severity of pulmonary arterial hypertension, right
ventricular dilatation and pulmonary and tricuspid regurgitation
in this particular group of patients were likely to have been
modest. On the other hand, it is conceivable that retrograde
transvalvular flow through the pulmonary valve could have
affected right ventricular and pulmonary arterial values. Sam-
ples were obtained sequentially, not simultaneously, and the
possibility exists that temporal changes in concentration
occurred in the different sampling sites as the catheter was
advanced into the pulmonary artery. To avoid this possibility,
care was taken to verify with fluoroscopy the position of the
catheter at each sampling site and the blood sampling proce-
dure was performed within a span of 5 min, with no changes
noted in heart rate or blood pressure in any of the patients.
Finally, Δ[Lac] and Δ[Glu] were small when compared with the
precision of the measuring instrument. This raises an important
question regarding the utility of single measurements of Δ[Lac]
and Δ[Glu], a question that only can be answered by further
clinical studies.
Conclusion
The development of ΔSO2 and Δ[Lac] in the patient population
studied cannot be explained by the mixing of SVC and IVC
blood. The development of these gradients appears to require
mixing with blood of lower SO2 and [Lac], most likely blood
emanating from the coronary sinus and Thebesian veins.
Because coronary venous blood SO2 and [Lac] vary accord-
ing to the rates of oxygen and lactate utilization by the heart,
this mechanism suggests a possible role for ΔSO2 and Δ[Lac]
as markers of myocardial energy metabolism in hemodynami-
cally stable individuals [6]. Further work remains to be done to
establish the provenance of these gradients in other clinical
conditions, including shock states [38].
Figure 1
Oxygen saturation and lactate concentration at the various sampling  sites Oxygen saturation and lactate concentration at the various sampling 
sites. Nine patients were included. Values are expressed as mean ± 
standard error. *P < 0.01, §P < 0.05 comparing right atrium (RA), right 
ventricle (RV) and pulmonary artery (PA) versus inferior vena cava 
(IVC). †P < 0.01, ¶P < 0.05 comparing RA, RV and PA versus superior 
vena cava (SVC).
Figure 2
Glucose concentration at the various sampling sites Glucose concentration at the various sampling sites. Nine patients 
were included. Values are expressed as mean ± standard error. *P < 
0.01 comparing inferior vena cava (IVC) versus superior vena cava 
(SVC). ¶P < 0.05 comparing right atrium (RA) and right ventricle (RV) 
versus SVC. PA, pulmonary artery.Critical Care    Vol 11 No 2    Gutierrez et al.
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